Autor:	Vicente Gimeno Ballester, Esmeralda Ríos Sánchez, Antonio Olry de Labry Lima, Antonio Matas Hoces, Emilio Jesús Alegre-Del Rey
Rok vydání:	2020
Předmět:	Transplantation medicine.medical_specialty Cost–benefit analysis Cost effectiveness business.industry Cost-Benefit Analysis MEDLINE Hematology Hematopoietic Stem Cells medicine Humans Autografts Multiple Myeloma Intensive care medicine business Lenalidomide medicine.drug
Zdroj:	Bone Marrow Transplantation. 55:853-854
ISSN:	1476-5365 0268-3369
DOI:	10.1038/s41409-020-0787-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc75ae138c208fdd70ef9aaa00b79eb4 https://doi.org/10.1038/s41409-020-0787-7 Zobrazit plný text záznamu Full text from SpringerLink